Cargando…
(111)In-exendin Uptake in the Pancreas Correlates With the β-Cell Mass and Not With the α-Cell Mass
Targeting of the GLP-1 receptor with (111)In-labeled exendin is an attractive approach to determine the β-cell mass (BCM). Preclinical studies as well as a proof-of-concept study in type 1 diabetic patients and healthy subjects showed a direct correlation between BCM and radiotracer uptake. Despite...
Autores principales: | Brom, Maarten, Joosten, Lieke, Frielink, Cathelijne, Boerman, Otto, Gotthardt, Martin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4876689/ https://www.ncbi.nlm.nih.gov/pubmed/25409700 http://dx.doi.org/10.2337/db14-1212 |
Ejemplares similares
-
Non-invasive in vivo determination of viable islet graft volume by (111)In-exendin-3
por: Eter, Wael A., et al.
Publicado: (2017) -
Graft revascularization is essential for non-invasive monitoring of transplanted islets with radiolabeled exendin
por: Eter, Wael A., et al.
Publicado: (2015) -
Strain Differences Determine the Suitability of Animal Models for Noninvasive In Vivo Beta Cell Mass Determination with Radiolabeled Exendin
por: Willekens, Stefanie M. A., et al.
Publicado: (2016) -
The effect of purification of Ga-68-labeled exendin on in vivo distribution
por: Brom, Maarten, et al.
Publicado: (2016) -
New Radiolabeled
Exendin Analogues Show Reduced Renal
Retention
por: Joosten, Lieke, et al.
Publicado: (2023)